Insights

Loading spinner
Gathering insights about Juvenescence®

Juvenescence® Tech Stack

Juvenescence® uses 8 technology products and services including Open Graph, Microsoft 365, Modernizr, and more. Explore Juvenescence®'s tech stack below.

  • Open Graph
    Content Management System
  • Microsoft 365
    Email
  • Modernizr
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Apple Pay
    Payment Processing
  • HSTS
    Security
  • Google Analytics
    Web Analytics

Media & News

Juvenescence®'s Email Address Formats

Juvenescence® uses at least 1 format(s):
Juvenescence® Email FormatsExamplePercentage
First@juvlabs.comJohn@juvlabs.com
64%
Last@juvlabs.comDoe@juvlabs.com
21%
First.Last@juvlabs.comJohn.Doe@juvlabs.com
12%
FL@juvlabs.comJD@juvlabs.com
3%

Frequently Asked Questions

What is Juvenescence®'s official website and social media links?

Minus sign iconPlus sign icon
Juvenescence®'s official website is juvlabs.com and has social profiles on LinkedInCrunchbase.

What is Juvenescence®'s SIC code NAICS code?

Minus sign iconPlus sign icon
Juvenescence®'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Juvenescence® have currently?

Minus sign iconPlus sign icon
As of December 2025, Juvenescence® has approximately 40 employees across 2 continents, including EuropeNorth America. Key team members include Cso - Juvenescence Life: M. D.Cfo: D. G.Chief Operating Officer - Coo: G. M.. Explore Juvenescence®'s employee directory with LeadIQ.

What industry does Juvenescence® belong to?

Minus sign iconPlus sign icon
Juvenescence® operates in the Biotechnology Research industry.

What technology does Juvenescence® use?

Minus sign iconPlus sign icon
Juvenescence®'s tech stack includes Open GraphMicrosoft 365ModernizrjQueryjQuery MigrateApple PayHSTSGoogle Analytics.

What is Juvenescence®'s email format?

Minus sign iconPlus sign icon
Juvenescence®'s email format typically follows the pattern of First@juvlabs.com. Find more Juvenescence® email formats with LeadIQ.

How much funding has Juvenescence® raised to date?

Minus sign iconPlus sign icon
As of December 2025, Juvenescence® has raised $76M in funding. The last funding round occurred on Apr 16, 2025 for $76M.

When was Juvenescence® founded?

Minus sign iconPlus sign icon
Juvenescence® was founded in 2016.

Juvenescence®

Biotechnology ResearchRamsey, Isle Of Man11-50 Employees

Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan. The Juvenescence team consists of highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in pharmaceutical drug development, synthetic biology, and tissue and cellular engineering.

Juvenescence has a broad pipeline in development and is driving innovation, with a focus on discovering and developing these therapies to modify the aging process, through prevention and by regenerating damage, to support healthy aging and increase health span.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $76M

    Juvenescence® has raised a total of $76M of funding over 5 rounds. Their latest funding round was raised on Apr 16, 2025 in the amount of $76M.

  • $25M$50M

    Juvenescence®'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $76M

    Juvenescence® has raised a total of $76M of funding over 5 rounds. Their latest funding round was raised on Apr 16, 2025 in the amount of $76M.

  • $25M$50M

    Juvenescence®'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.